Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation

Abstract Pulmonary vein isolation (PVI) using cryoenergy is safe and efficient for treatment of atrial fibrillation (AF). Pre-existing upper gastrointestinal (GI) pathologies have been shown to increase the risk for AF. Therefore, this study aimed at assessing incidental pathologies of the upper GI...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: F. Cordes, C. Ellermann, D. G. Dechering, G. Frommeyer, S. Kochhäuser, P. S. Lange, C. Pott, F. Lenze, I. Kabar, H. Schmidt, H. Ullerich, L. Eckardt
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/eca5b7a351774d04918773b9736cd77e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eca5b7a351774d04918773b9736cd77e
record_format dspace
spelling oai:doaj.org-article:eca5b7a351774d04918773b9736cd77e2021-12-02T15:53:45ZPre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation10.1038/s41598-021-83928-02045-2322https://doaj.org/article/eca5b7a351774d04918773b9736cd77e2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83928-0https://doaj.org/toc/2045-2322Abstract Pulmonary vein isolation (PVI) using cryoenergy is safe and efficient for treatment of atrial fibrillation (AF). Pre-existing upper gastrointestinal (GI) pathologies have been shown to increase the risk for AF. Therefore, this study aimed at assessing incidental pathologies of the upper GI tract in patients scheduled for PVI and to analyse the impact of patients’ characteristics on PVI safety outcome. In 71 AF patients, who participated in the MADE-PVI trial, oesophagogastroduodenoscopy and endosonography were prospectively performed directly before and the day after PVI to assess pre-existing upper GI pathologies and post-interventional occurrence of PVI-associated lesions. Subgroup analysis of the MADE-PVI trial identified clinically relevant incidental findings in 53 patients (74.6%) with age > 50 years being a significant risk factor. Pre-existing reflux oesophagitis increased risk for PVI-associated mediastinal oedema, while patients already treated with proton pump inhibitors (PPI) had significantly fewer mediastinal oedema. Our results suggest that AF patients with pre-existing reflux oesophagitis are at higher risk for PVI-associated mediastinal lesions, which is decreased in patients with constant PPI-treatment prior to PVI. Since PVI-associated mediastinal lesions are regarded as surrogate parameter for an increased risk of the fatal complication of an oesophago-atrial fistula, our findings hint at a beneficial effect of pre-interventional prophylactic PPI-treatment to reduce risk for PVI-associated complications. German Clinical Trials Register (DRKS00016006; date of registration: 17/12/2018).F. CordesC. EllermannD. G. DecheringG. FrommeyerS. KochhäuserP. S. LangeC. PottF. LenzeI. KabarH. SchmidtH. UllerichL. EckardtNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
F. Cordes
C. Ellermann
D. G. Dechering
G. Frommeyer
S. Kochhäuser
P. S. Lange
C. Pott
F. Lenze
I. Kabar
H. Schmidt
H. Ullerich
L. Eckardt
Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
description Abstract Pulmonary vein isolation (PVI) using cryoenergy is safe and efficient for treatment of atrial fibrillation (AF). Pre-existing upper gastrointestinal (GI) pathologies have been shown to increase the risk for AF. Therefore, this study aimed at assessing incidental pathologies of the upper GI tract in patients scheduled for PVI and to analyse the impact of patients’ characteristics on PVI safety outcome. In 71 AF patients, who participated in the MADE-PVI trial, oesophagogastroduodenoscopy and endosonography were prospectively performed directly before and the day after PVI to assess pre-existing upper GI pathologies and post-interventional occurrence of PVI-associated lesions. Subgroup analysis of the MADE-PVI trial identified clinically relevant incidental findings in 53 patients (74.6%) with age > 50 years being a significant risk factor. Pre-existing reflux oesophagitis increased risk for PVI-associated mediastinal oedema, while patients already treated with proton pump inhibitors (PPI) had significantly fewer mediastinal oedema. Our results suggest that AF patients with pre-existing reflux oesophagitis are at higher risk for PVI-associated mediastinal lesions, which is decreased in patients with constant PPI-treatment prior to PVI. Since PVI-associated mediastinal lesions are regarded as surrogate parameter for an increased risk of the fatal complication of an oesophago-atrial fistula, our findings hint at a beneficial effect of pre-interventional prophylactic PPI-treatment to reduce risk for PVI-associated complications. German Clinical Trials Register (DRKS00016006; date of registration: 17/12/2018).
format article
author F. Cordes
C. Ellermann
D. G. Dechering
G. Frommeyer
S. Kochhäuser
P. S. Lange
C. Pott
F. Lenze
I. Kabar
H. Schmidt
H. Ullerich
L. Eckardt
author_facet F. Cordes
C. Ellermann
D. G. Dechering
G. Frommeyer
S. Kochhäuser
P. S. Lange
C. Pott
F. Lenze
I. Kabar
H. Schmidt
H. Ullerich
L. Eckardt
author_sort F. Cordes
title Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
title_short Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
title_full Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
title_fullStr Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
title_full_unstemmed Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
title_sort pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/eca5b7a351774d04918773b9736cd77e
work_keys_str_mv AT fcordes preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT cellermann preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT dgdechering preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT gfrommeyer preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT skochhauser preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT pslange preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT cpott preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT flenze preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT ikabar preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT hschmidt preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT hullerich preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
AT leckardt preproceduralprotonpumpinhibitionisassociatedwithfewerperioesophageallesionsaftercryoballoonpulmonaryveinisolation
_version_ 1718385545846980608